Welcome to our dedicated page for BioSig Technologies news (Ticker: BSGM), a resource for investors and traders seeking the latest updates and insights on BioSig Technologies stock.
BioSig Technologies Inc. (NASDAQ: BSGM) provides cutting-edge solutions in cardiac electrophysiology through its flagship PURE EP™ System. This page serves as the definitive source for official company news, including financial results, regulatory milestones, and clinical advancements.
Investors and healthcare professionals will find curated updates on product innovations, partnership announcements, and peer-reviewed research validating BioSig's signal processing technology. Key coverage areas: quarterly earnings reports, FDA clearances, hospital adoption metrics, and intellectual property developments.
All content undergoes strict verification to ensure alignment with SEC disclosure standards and medical device reporting regulations. Bookmark this page for real-time updates on BSGM's progress in enhancing cardiac ablation accuracy through advanced signal visualization technology.
BioSig Technologies (NASDAQ: BSGM), following its merger with Streamex Exchange Corporation, has engaged Compliance Exchange Group (CXG) to acquire a FINRA and SEC registered broker-dealer. This strategic move positions Streamex to become one of the first Nasdaq-listed companies offering regulated Real-World Asset (RWA) tokenization services.
The acquisition aims to tap into the $22 trillion global gold market within the $142 trillion commodities sector. The company's Solana-based blockchain platform will enable efficient issuance and trading of gold-backed tokens, making gold investment more accessible to both institutional and retail investors. Streamex plans to hold significant vaulted gold quantities by 2026, denominating its balance sheet in physical gold to support a recurring revenue model.
BioSig Technologies (NASDAQ: BSGM) has announced the appointment of Russell Starr as Strategic Advisor to Streamex following their recent merger. Starr, a former Bay Street executive and ex-CEO of DeFi Technologies, brings significant expertise in capital markets and decentralized finance. During his tenure at DeFi Technologies, he led the company to achieve over $200M USD in yearly revenue and grew the share price from $0.07 USD to $4.95 USD.
Starr joins Streamex's distinguished Advisory Board, which includes notable figures such as Frank Giustra (founder of Wheaton Precious Metals), Sean Roosen (founder of Osisko Development Corp), and other industry leaders. The appointment aligns with Streamex's mission to advance tokenized commodities and blockchain infrastructure development.
BioSig Technologies (NASDAQ: BSGM) has announced the appointment of Russell Starr as Strategic Advisor to Streamex, following the company's recent merger with Streamex Exchange Corporation. Starr, formerly Head of Capital Markets Consultant at DeFi Technologies, brings extensive experience in capital markets, business development, and transformative deal-making.
The appointment strengthens Streamex's already impressive Advisory Board, which includes notable industry leaders such as Frank Giustra, founder of Wheaton Precious Metals ($37B) and GoldCorp, Sean Roosen of Osisko Development Corp, and other strategic advisors specializing in various aspects of capital markets, DeFi, and tokenized assets.
This strategic move aims to enhance Streamex's position in the tokenized asset space, combining Starr's expertise in decentralized finance with the company's focus on bringing commodities on chain.
BioSig Technologies (NASDAQ: BSGM) has issued a correction to their July 11, 2025 press release regarding Russell Starr's appointment as Strategic Advisor to Streamex. The correction clarifies that during his time at DeFi Technologies, Starr served as Head of Capital Markets Consultant, not as CEO as previously implied.
The company corrected statements about Starr's role in DeFi Technologies' growth from $0.07 to $4.95 per share and achieving over $200M in yearly revenue. While at DeFi Technologies, Starr contributed to the company's strategic focus on Web3 infrastructure and helped facilitate its Nasdaq listing.
BioSig Technologies (NASDAQ:BSGM) has secured up to $1.1 billion in growth financing through definitive agreements with institutional investors. The financing includes $100 million in senior secured convertible debentures and a $1 billion equity line of credit over 36 months.
The company, which recently merged with Streamex Exchange Corporation, aims to become one of Nasdaq's largest public holders of gold bullion and plans to tokenize the $142 trillion commodities market using Streamex's real-world asset (RWA) platform powered by Solana blockchain. The debentures have a 24-month maturity with 4% annual interest, convertible into common stock.
The transaction, expected to close around October 7, 2025, was led by Cantor Fitzgerald & Co., Clear Street LLC, and Needham & Company as placement agents, with CIBC World Markets acting as Strategic Advisor.
BioSig Technologies (NASDAQ: BSGM) and Streamex Exchange Corporation have appointed Mitch Williams, CFA, as their Chief Investment Officer. Williams, a former executive at OppenheimerFunds and Wafra Inc., brings over 20 years of capital markets experience to the combined company. At Wafra Inc., he achieved more than 3-fold growth in Global Equity assets and delivered top-quartile performance consistently.
As CIO, Williams will lead the companies' strategic vision and commodity tokenization initiatives, focusing on penetrating the $142.85 trillion global commodity market through real world asset (RWA) tokenization solutions. He will report directly to CEO Henry McPhie. Williams, who was previously an early investor and Strategic Advisor to Streamex, views RWA tokenization as a scalable technology and sees Streamex as a unique investment opportunity combining fiat currency hedging with recurring revenue.
BioSig Technologies (NASDAQ: BSGM) has appointed Mitch Williams, CFA, as Chief Investment Officer following its acquisition of Streamex Exchange Corporation. Williams, a former executive at OppenheimerFunds and Wafra Inc., brings over 20 years of capital markets experience to advance the company's mission in real world asset tokenization and commodity markets.
At Wafra Inc., Williams demonstrated exceptional performance by growing assets more than 3-fold and maintaining top-quartile performance. At OppenheimerFunds, he was the top-ranked equity analyst leading the firm's flagship fund. In his new role, Williams will oversee the company's strategic vision and commodity tokenization initiatives within the $142.851 trillion global commodity market, reporting directly to CEO Henry McPhie.
BioSig Technologies (NASDAQ: BSGM) and Streamex Exchange Corporation have completed their share exchange transaction, transforming into a company focused on real-world asset tokenization, particularly in the commodities sector. The deal positions the combined entity to tap into the $142.85 trillion global commodity market.
Key leadership changes include Streamex's Co-Founder Henry McPhie becoming CEO and joining the Board, while Co-Founder Morgan Lekstrom will serve as Chairman. Former BioSig CEO Anthony Amato will remain on the Board. Notable strategic additions include Frank Giustra, founder of Wheaton Precious Metals and GoldCorp, as Strategic Investor and Advisor on Commodities, and Mathew August as Strategic Advisor on US Capital Markets.
FAQ
What is the current stock price of BioSig Technologies (BSGM)?
What is the market cap of BioSig Technologies (BSGM)?
